Stockscreener 앱 받기
30.61
0.10%
0.125
전일 마감가:
$30.73
열려 있는:
$30.68
하루 거래량:
35,147
Relative Volume:
0.02
시가총액:
$4.85B
수익:
$264.79M
순이익/손실:
$-14.36M
주가수익비율:
-278.23
EPS:
-0.11
순현금흐름:
$-28.11M
1주 성능:
-1.19%
1개월 성능:
-3.97%
6개월 성능:
-17.53%
1년 성능:
-4.35%
1일 변동 폭
$30.54
$30.99
1주일 범위
$29.79
$31.44
52주 변동 폭
$25.28
$46.48
TG테라퓨틱스사 Stock (TGTX) Company Profile
명칭
Tg Therapeutics Inc
전화
(212) 554-4484
주소
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
TGTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
30.55 | 4.88B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.06 | 116.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
789.96 | 82.52B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
395.54 | 52.67B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
850.67 | 52.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.54 | 37.70B | 447.02M | -1.18B | -906.14M | -6.1812 |
TG테라퓨틱스사 Stock (TGTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-06 | 재개 | H.C. Wainwright | Buy |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2024-10-29 | 개시 | TD Cowen | Buy |
| 2023-08-02 | 업그레이드 | Goldman | Sell → Neutral |
| 2023-06-26 | 재개 | Jefferies | Buy |
| 2022-05-20 | 개시 | BofA Securities | Underperform |
| 2022-02-23 | 재확인 | B. Riley Securities | Buy |
| 2021-11-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-04-20 | 개시 | Goldman | Neutral |
| 2021-04-19 | 재확인 | H.C. Wainwright | Buy |
| 2020-09-01 | 개시 | JP Morgan | Overweight |
| 2020-08-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-05 | 개시 | Evercore ISI | Outperform |
| 2020-01-17 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-27 | 재개 | B. Riley FBR | Buy |
| 2019-02-06 | 재개 | Jefferies | Buy |
| 2018-09-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 재개 | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 재개 | H.C. Wainwright | Buy |
| 2017-04-25 | 개시 | Jefferies | Buy |
| 2017-03-06 | 재확인 | FBR & Co. | Outperform |
| 2016-10-06 | 재개 | Brean Capital | Buy |
| 2016-05-27 | 개시 | SunTrust | Buy |
| 2015-12-01 | 개시 | FBR Capital | Outperform |
| 2015-09-09 | 개시 | Raymond James | Strong Buy |
| 2015-08-12 | 재개 | H.C. Wainwright | Buy |
| 2015-06-19 | 재확인 | Brean Capital | Buy |
| 2014-12-11 | 재확인 | ROTH Capital | Buy |
| 2014-12-10 | 재확인 | ROTH Capital | Buy |
모두보기
TG테라퓨틱스사 주식(TGTX)의 최신 뉴스
Trading the Move, Not the Narrative: (TGTX) Edition - news.stocktradersdaily.com
Will TG Therapeutics Inc. stock remain a Wall Street favorite2025 Support & Resistance & Consistent Profit Trading Strategies - Улправда
Can TG Therapeutics Inc. stock surprise with earnings upsideQuarterly Earnings Report & Technical Pattern Based Signals - Улправда
Can TG Therapeutics Inc. stock sustain institutional interest2025 Market Overview & Short-Term Trading Alerts - DonanımHaber
Is the Options Market Predicting a Spike in TG Therapeutics Stock? - Zacks Investment Research
How buybacks impact TG Therapeutics Inc. stock valueTrade Risk Report & Free Risk Controlled Daily Trade Plans - Улправда
Can TG Therapeutics Inc. stock resist sector downturns2025 Earnings Surprises & Daily Profit Maximizing Tips - Улправда
Is TG Therapeutics Inc. (NKB2) stock expanding market penetration2025 Trade Ideas & AI Forecasted Entry and Exit Points - ulpravda.ru
Why TG Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Summary & Expert-Curated Trade Recommendations - Улправда
Earnings Recap: Why TG Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Snapshot & Risk Controlled Stock Alerts - Улправда
Will TG Therapeutics Inc. stock benefit from automationMarket Activity Report & Free Expert Verified Stock Movement Alerts - Улправда
Why TG Therapeutics Inc. stock remains on watchlistsJuly 2025 Highlights & Community Driven Trade Alerts - Улправда
TG Therapeutics (TGTX) Lags Q1 Earnings Estimates - sharewise.com
Marex Group plc Makes New $10.02 Million Investment in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Rating Increased to Buy at Wall Street Zen - MarketBeat
Eventide Asset Management LLC Increases Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
(TGTX) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Norges Bank Makes New Investment in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Bought by Diadema Partners LP - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Acquired by Jump Financial LLC - MarketBeat
Is TG Therapeutics (TGTX) Quietly Reframing Its Investment Story Around Neurology Depth Over Breadth? - Sahm
1832 Asset Management L.P. Has $5.18 Million Stock Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Lacklustre Performance Is Driving TG Therapeutics, Inc.'s (NASDAQ:TGTX) Low P/S - 富途牛牛
New York State Common Retirement Fund Boosts Stake in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
TG Therapeutics, Inc. $TGTX Shares Bought by Russell Investments Group Ltd. - MarketBeat
Is TG Therapeutics Inc. (NKB2) stock nearing a technical breakout2025 Trading Recap & Verified Swing Trading Watchlists - Newser
Is TG Therapeutics Still Attractively Priced After Recent Multiple Sclerosis Expansion Progress? - Sahm
Why TG Therapeutics Inc. (NKB2) stock stays resilient2025 Analyst Calls & Fast Entry High Yield Stock Tips - Newser
TG Therapeutics (TGTX) Earnings Date and Reports 2026 - MarketBeat
TG Therapeutics (TGTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
With TG Therapeutics Stock Sliding, Have You Assessed The Risk? - Trefis
Legal & General Group Plc Has $13.18 Million Stock Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Acquired by Prudential Financial Inc. - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Price-Driven Insight from (TGTX) for Rule-Based Strategy - news.stocktradersdaily.com
Is TG Therapeutics Inc NKB2 a good long term investmentGrowth Stock Opportunities & Affordable Investment Portfolio - earlytimes.in
11,012 Shares in TG Therapeutics, Inc. $TGTX Purchased by Inceptionr LLC - MarketBeat
Can Clinical Progress Updates Boost TG Therapeutics' Value in 2025? - Yahoo Finance
11,676 Shares in TG Therapeutics, Inc. $TGTX Bought by Rockefeller Capital Management L.P. - MarketBeat
TG Therapeutics (TGTX): Assessing Valuation and Growth Narrative Following Recent Market Attention - Sahm
TG Therapeutics CEO Michael S. Weiss to Speak at 8th Annual Evercore Healthcare Conference - Quiver Quantitative
TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times
TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit - Sahm
TG Therapeutics (TGTX) Is Up After Raising 2025 Revenue Guidance Has the Growth Story Strengthened? - Sahm
TG Therapeutics TGTX Q3 2025 Earnings Transcript - Nasdaq
Summit Global Investments Purchases Shares of 12,216 TG Therapeutics, Inc. $TGTX - MarketBeat
Rhenman & Partners Asset Management AB Sells 62,500 Shares of TG Therapeutics, Inc. $TGTX - MarketBeat
Director At TG Therapeutics Sells $162K Of Stock - Benzinga
Yann Echelard Sells 5,000 Shares of TG Therapeutics (NASDAQ:TGTX) Stock - MarketBeat
TG테라퓨틱스사 (TGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.28%
0.98%
자본화:
|
볼륨(24시간):